Christopher Sweeney

Christopher Sweeney: Email & Phone Number

Opt-Out
Executive Director, Intellectual Property at Acuitas Therapeutics|Bothell, Washington, United States

Position:

Executive Director, Intellectual Property at Acuitas Therapeutics

Location:

Bothell, Washington, United States

LinkedIn
View Christopher Sweeney's Email
Up to 10 free lookups. No credit card required.
Last updated: 2026-05-14
Updated: 2026-05-14

Found email addresses for Christopher Sweeney:

Business emails:

Found phone for Christopher Sweeney:

Searching for Christopher Sweeney profiles
0% completed

A different Christopher Sweeney?

Sign up to search for other Christopher Sweeney's across our 850M+ professionals database

Work Experience 27 years

Executive Director, Intellectual Property at Acuitas Therapeutics

Jun 2024 - Current

Executive Director at Pfizer

Dec 2023 - Jun 2024

Executive Director at Seagen

Aug 2023 - Dec 2023

Senior Director, Intellectual Property at Seagen

May 2018 - Aug 2023

Partner at Knobbe Martens

Sep 2004 - Apr 2018

Associate at Knobbe Martens Olson & Bear LLP

Sep 2004 - Dec 2010

Research Scientist at ALK

Jul 1999 - Aug 2000

Christopher Sweeney started working in 1999, then the employee has changed 5 companies and 5 jobs. On average, Christopher Sweeney works for one company for 4 years 2 months.

Their professional focus is Biochemistry, Biotechnology, and Business Strategy across 3 core areas.

Education

J.D. at University of Washington School of Law

M.S. at University of Oregon

B.S. at Gonzaga University

High School at Gonzaga Prep

Frequently Asked Questions

What is Christopher Sweeney's email address?

SignalHire found a verified business email address for Christopher Sweeney: s*******c@acuitastx.com.

What is Christopher Sweeney's phone number?

SignalHire found a verified phone number for Christopher Sweeney: +1-***-***-3751.

How do I contact Christopher Sweeney at Acuitas Therapeutics?

You can reach Christopher Sweeney through SignalHire by unlocking their verified email and direct phone number (free signup, no credit card needed). SignalHire is the fastest route if you need their contact details immediately.

What is Christopher Sweeney's professional background?

Christopher Sweeney has 27 years of professional experience. They have held roles including Executive Director, Executive Director, and Senior Director, Intellectual Property at companies such as Pfizer, Seagen, and Seagen. Their education includes J.D. from University of Washington School of Law, and M.S. from University of Oregon.

Is Christopher Sweeney's contact information up to date?

Yes. Christopher Sweeney's SignalHire profile was last updated on 14 May 2026, reflecting their current position as Executive Director, Intellectual Property at Acuitas Therapeutics in Vancouver, British Columbia, Canada.

Christopher Sweeney Namesakes

Name
Company
Position
Christopher Sweeney
Global Enterprise Manager
Get contacts
Christopher Sweeney
Soldier Recovery Unit Battalion
Executive Officer
Get contacts
Christopher Sweeney
CreativeTrail
Co-Founder
Get contacts
See more profiles

Other employees at Acuitas Therapeutics

Name
Company
Position
Susmith Tadimari
Cyber Security Analyst
Get contacts
Hannah Yun
Analytical Co-op
Get contacts
Ishana Sookoor
Immunology/Preclinical Co-op
Get contacts
Pinn Yee Scott
Chemistry Co-op Student
Get contacts
Tara Jackson
Formulation Development
Get contacts
Jonathan May
Senior Scientist
Get contacts
Meg Valeur
Member Board of Directors
Get contacts
Jade Tam
Business Development Intern
Get contacts
Tsewang Diki
Research Assistant
Get contacts
See more profiles

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP